The ability of Maritoclax to repress more than one anti-apoptotic protein may explain the single agent activity of Maritoclax in both the NPC cell lines as repression of MCL-1 and BCL-2/BCL-XL may be sufficient to reduce the threshold for apoptosis activation. The gene discussed is BCL2; the disease is nasopharyngeal carcinoma.